Abstract
Summary
According to our LPI (LP Information) latest study, the global CRISPR & Cas9 market size was valued at US$ million in 2023. With growing demand in downstream market, the CRISPR & Cas9 is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global CRISPR & Cas9 market. CRISPR & Cas9 are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of CRISPR & Cas9. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the CRISPR & Cas9 market.
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
Key Features:
The report on CRISPR & Cas9 market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the CRISPR & Cas9 market. It may include historical data, market segmentation by Type (e.g., Genome Editing, Genetic Engineering), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the CRISPR & Cas9 market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the CRISPR & Cas9 market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the CRISPR & Cas9 industry. This include advancements in CRISPR & Cas9 technology, CRISPR & Cas9 new entrants, CRISPR & Cas9 new investment, and other innovations that are shaping the future of CRISPR & Cas9.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the CRISPR & Cas9 market. It includes factors influencing customer ' purchasing decisions, preferences for CRISPR & Cas9 product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the CRISPR & Cas9 market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting CRISPR & Cas9 market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the CRISPR & Cas9 market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the CRISPR & Cas9 industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the CRISPR & Cas9 market.
Market Segmentation:
CRISPR & Cas9 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segmentation by application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
The research report highlights the growth potential of the global CRISPR & Cas9 market. CRISPR & Cas9 are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of CRISPR & Cas9. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the CRISPR & Cas9 market.
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
Key Features:
The report on CRISPR & Cas9 market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the CRISPR & Cas9 market. It may include historical data, market segmentation by Type (e.g., Genome Editing, Genetic Engineering), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the CRISPR & Cas9 market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the CRISPR & Cas9 market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the CRISPR & Cas9 industry. This include advancements in CRISPR & Cas9 technology, CRISPR & Cas9 new entrants, CRISPR & Cas9 new investment, and other innovations that are shaping the future of CRISPR & Cas9.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the CRISPR & Cas9 market. It includes factors influencing customer ' purchasing decisions, preferences for CRISPR & Cas9 product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the CRISPR & Cas9 market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting CRISPR & Cas9 market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the CRISPR & Cas9 market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the CRISPR & Cas9 industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the CRISPR & Cas9 market.
Market Segmentation:
CRISPR & Cas9 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segmentation by application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CRISPR & Cas9 Market Size 2019-2030
2.1.2 CRISPR & Cas9 Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 CRISPR & Cas9 Segment by Type
2.2.1 Genome Editing
2.2.2 Genetic Engineering
2.2.3 gRNA Database/Gene Librar
2.2.4 CRISPR Plasmid
2.2.5 Human Stem Cells
2.2.6 Genetically Modified Organisms/Crops
2.2.7 Cell Line Engineering
2.3 CRISPR & Cas9 Market Size by Type
2.3.1 CRISPR & Cas9 Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CRISPR & Cas9 Market Size Market Share by Type (2019-2024)
2.4 CRISPR & Cas9 Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Academic Institutes
2.4.4 Research and Development Institutes
2.5 CRISPR & Cas9 Market Size by Application
2.5.1 CRISPR & Cas9 Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CRISPR & Cas9 Market Size Market Share by Application (2019-2024)
3 CRISPR & Cas9 Market Size by Player
3.1 CRISPR & Cas9 Market Size Market Share by Players
3.1.1 Global CRISPR & Cas9 Revenue by Players (2019-2024)
3.1.2 Global CRISPR & Cas9 Revenue Market Share by Players (2019-2024)
3.2 Global CRISPR & Cas9 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR & Cas9 by Regions
4.1 CRISPR & Cas9 Market Size by Regions (2019-2024)
4.2 Americas CRISPR & Cas9 Market Size Growth (2019-2024)
4.3 APAC CRISPR & Cas9 Market Size Growth (2019-2024)
4.4 Europe CRISPR & Cas9 Market Size Growth (2019-2024)
4.5 Middle East & Africa CRISPR & Cas9 Market Size Growth (2019-2024)
5 Americas
5.1 Americas CRISPR & Cas9 Market Size by Country (2019-2024)
5.2 Americas CRISPR & Cas9 Market Size by Type (2019-2024)
5.3 Americas CRISPR & Cas9 Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR & Cas9 Market Size by Region (2019-2024)
6.2 APAC CRISPR & Cas9 Market Size by Type (2019-2024)
6.3 APAC CRISPR & Cas9 Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CRISPR & Cas9 by Country (2019-2024)
7.2 Europe CRISPR & Cas9 Market Size by Type (2019-2024)
7.3 Europe CRISPR & Cas9 Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CRISPR & Cas9 by Region (2019-2024)
8.2 Middle East & Africa CRISPR & Cas9 Market Size by Type (2019-2024)
8.3 Middle East & Africa CRISPR & Cas9 Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CRISPR & Cas9 Market Forecast
10.1 Global CRISPR & Cas9 Forecast by Regions (2025-2030)
10.1.1 Global CRISPR & Cas9 Forecast by Regions (2025-2030)
10.1.2 Americas CRISPR & Cas9 Forecast
10.1.3 APAC CRISPR & Cas9 Forecast
10.1.4 Europe CRISPR & Cas9 Forecast
10.1.5 Middle East & Africa CRISPR & Cas9 Forecast
10.2 Americas CRISPR & Cas9 Forecast by Country (2025-2030)
10.2.1 United States CRISPR & Cas9 Market Forecast
10.2.2 Canada CRISPR & Cas9 Market Forecast
10.2.3 Mexico CRISPR & Cas9 Market Forecast
10.2.4 Brazil CRISPR & Cas9 Market Forecast
10.3 APAC CRISPR & Cas9 Forecast by Region (2025-2030)
10.3.1 China CRISPR & Cas9 Market Forecast
10.3.2 Japan CRISPR & Cas9 Market Forecast
10.3.3 Korea CRISPR & Cas9 Market Forecast
10.3.4 Southeast Asia CRISPR & Cas9 Market Forecast
10.3.5 India CRISPR & Cas9 Market Forecast
10.3.6 Australia CRISPR & Cas9 Market Forecast
10.4 Europe CRISPR & Cas9 Forecast by Country (2025-2030)
10.4.1 Germany CRISPR & Cas9 Market Forecast
10.4.2 France CRISPR & Cas9 Market Forecast
10.4.3 UK CRISPR & Cas9 Market Forecast
10.4.4 Italy CRISPR & Cas9 Market Forecast
10.4.5 Russia CRISPR & Cas9 Market Forecast
10.5 Middle East & Africa CRISPR & Cas9 Forecast by Region (2025-2030)
10.5.1 Egypt CRISPR & Cas9 Market Forecast
10.5.2 South Africa CRISPR & Cas9 Market Forecast
10.5.3 Israel CRISPR & Cas9 Market Forecast
10.5.4 Turkey CRISPR & Cas9 Market Forecast
10.5.5 GCC Countries CRISPR & Cas9 Market Forecast
10.6 Global CRISPR & Cas9 Forecast by Type (2025-2030)
10.7 Global CRISPR & Cas9 Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Information
11.1.2 Caribou Biosciences CRISPR & Cas9 Product Offered
11.1.3 Caribou Biosciences CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Caribou Biosciences Main Business Overview
11.1.5 Caribou Biosciences Latest Developments
11.2 Integrated DNA Technologies(IDT)
11.2.1 Integrated DNA Technologies(IDT) Company Information
11.2.2 Integrated DNA Technologies(IDT) CRISPR & Cas9 Product Offered
11.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Integrated DNA Technologies(IDT) Main Business Overview
11.2.5 Integrated DNA Technologies(IDT) Latest Developments
11.3 CRISPR Therapeutics
11.3.1 CRISPR Therapeutics Company Information
11.3.2 CRISPR Therapeutics CRISPR & Cas9 Product Offered
11.3.3 CRISPR Therapeutics CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 CRISPR Therapeutics Main Business Overview
11.3.5 CRISPR Therapeutics Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck CRISPR & Cas9 Product Offered
11.4.3 Merck CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Mirus Bio
11.5.1 Mirus Bio Company Information
11.5.2 Mirus Bio CRISPR & Cas9 Product Offered
11.5.3 Mirus Bio CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Mirus Bio Main Business Overview
11.5.5 Mirus Bio Latest Developments
11.6 Editas Medicine
11.6.1 Editas Medicine Company Information
11.6.2 Editas Medicine CRISPR & Cas9 Product Offered
11.6.3 Editas Medicine CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Editas Medicine Main Business Overview
11.6.5 Editas Medicine Latest Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Information
11.7.2 Takara Bio CRISPR & Cas9 Product Offered
11.7.3 Takara Bio CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Takara Bio Main Business Overview
11.7.5 Takara Bio Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific CRISPR & Cas9 Product Offered
11.8.3 Thermo Fisher Scientific CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Information
11.9.2 Horizon Discovery Group CRISPR & Cas9 Product Offered
11.9.3 Horizon Discovery Group CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Horizon Discovery Group Main Business Overview
11.9.5 Horizon Discovery Group Latest Developments
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Information
11.10.2 Intellia Therapeutics CRISPR & Cas9 Product Offered
11.10.3 Intellia Therapeutics CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Intellia Therapeutics Main Business Overview
11.10.5 Intellia Therapeutics Latest Developments
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Information
11.11.2 Agilent Technologies CRISPR & Cas9 Product Offered
11.11.3 Agilent Technologies CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Agilent Technologies Main Business Overview
11.11.5 Agilent Technologies Latest Developments
11.12 Cellecta
11.12.1 Cellecta Company Information
11.12.2 Cellecta CRISPR & Cas9 Product Offered
11.12.3 Cellecta CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cellecta Main Business Overview
11.12.5 Cellecta Latest Developments
11.13 GenScript
11.13.1 GenScript Company Information
11.13.2 GenScript CRISPR & Cas9 Product Offered
11.13.3 GenScript CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 GenScript Main Business Overview
11.13.5 GenScript Latest Developments
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Information
11.14.2 GeneCopoeia CRISPR & Cas9 Product Offered
11.14.3 GeneCopoeia CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 GeneCopoeia Main Business Overview
11.14.5 GeneCopoeia Latest Developments
11.15 Synthego
11.15.1 Synthego Company Information
11.15.2 Synthego CRISPR & Cas9 Product Offered
11.15.3 Synthego CRISPR & Cas9 Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Synthego Main Business Overview
11.15.5 Synthego Latest Developments
12 Research Findings and Conclusion